The present study assessed the use of different antibiotic classes in the treatment of infections in hospitalized children under 12 years old. In our study, the intravenous infusion route was the most common form of antibiotic administration followed by the combination of parenteral and oral route for pediatric patients, which is similar to other studies in Ethiopia and India (
13,
14), but it is higher than similar study in Nepal (
15). Our results showed that febrile convulsions (34.4%) were the most frequent indication for antibiotic prescription, followed by upper respiratory tract infections (25.5%) and pyrexia with unknown origin (17.6%). In some other studies, pneumonia is the leading cause of hospitalization in children (
13,
14,
16). Acute otitis media and upper respiratory tract infection were the main clinical findings in hospitalized children in Germany, and fever was the most frequent cause of children’s hospitalization in Saudi Arabia (
6,
17). Acute gastroenteritis and respiratory illnesses are the major causes of morbidity and mortality in children under five years of age, for which inappropriate antibiotic utilization for the treatment of cough/cold and/or diarrhea in pediatric patients is the most common (
18). In most cases, no antibiotic therapy is needed for the treatment of acute diarrhea in children, and rehydration is the key treatment (
19).
This study showed that 3rd generation cephalosporins were the most frequently prescribed antibiotics, followed by macrolides, vancomycin, and metronidazole. Ceftriaxone was the most commonly prescribed antibiotic, followed by clindamycin and vancomycin. There is variability in antibiotic prescription for hospitalized children and typically the prescription of a higher proportion of broad-spectrum antibiotics. Although cephalosporins, macrolides, vancomycin, and metronidazole are the most frequently prescribed antibiotic classes for children, their pattern of administration is varied in different countries (
4,
6,
17). Cephalosporins have been the most frequently prescribed antibiotic classes in hospitalized children in many countries including Canada (
20), Saudi Arabia (
17), India (
14), Nepal (
16), and United States (
2). Macrolides were the most frequently prescribed antibiotic classes for children in Germany (
6); however, penicillins were the most common antibiotics in Brazil (
7) and Greece (
21).
Consistent with this study, Ceftriaxone 369 (82.0%), clindamycin 51 (11.3%), and vancomycin 15 (3.3%) were the three most commonly used antibiotics in hospitalized children. Meropenem, a carbapenem antibiotic, was prescribed in 1.1% of children and 3.1% of patients received the combination of cefotaxime and ampicillin. Cefazoline, 1st generation cephalosporin, was the most frequently antibiotic used in Canada (
20) and United States (
2). In our study ampicillin was the most frequently prescribed penicillin, which was used in combination with cefotaxime, a 3rd generation cephalosporin, in only 3.1% of the patients. However, in similar studies, amoxicillin was the most frequently prescribed antibiotics in Brazil (
7), Greece (
21), India (
14). Gentamicin has been used as the first choice for hospitalized infants in NICU patients in the United States (
2) and pediatric patients in Nigeria (
4).
The 3rd generation cephalosporins (ceftriaxone and cefotaxime) and carbapenems (meropenem) are among expensive drugs and should usually be reserved for treatment of serious infections caused by organisms resistant to other antibiotics, including penicillin-resistant pneumococci (PRSP strains). Also, vancomycin is used for the treatment of drug-resistant gram-positive organisms, including methicillin-resistant staphylococci (MRSA), and penicillin-resistant pneumococci (PRSP) that is used in combination with a third-generation cephalosporin. Since in this study, most antibiotics (84%) are prescribed on an empirical basis, the high rate prescription of these antibiotics could be an indication of inappropriate use of antibiotics. In this regard, antibiotic restriction policies should be applied for the promotion of the rational use of antibiotics, thereby resulting in a significant reduction of antibiotic use and hospitalization costs (
22). Vancomycin was among the most commonly prescribed antibiotics for hospitalized children in Canada (
20) and NICU patients in the United States (
2). Inappropriate use of fluoroquinolones for hospitalized pediatric patients is reported in Brazil (
7), Saudi Arabia (
17) and India (
14).
In our studies, the hospitalized children received antibiotics for more than five days (5.1 d in febrile vs 5.2 d in non-febrile patients). It is reported that empirical antibiotic therapy for more than five days increases the risk of necrotizing enterocolitis or death in extremely low birth weight infants (
23). Also, antibiotic therapy increase the risk of
Clostridium difficile infection, ranging from severe diarrhea, pseudomembranous colitis, toxic megacolon, bowel perforation, and death in hospitalized children (
24). Qureshi et al. (2013) reported that hospitalization of patients with transient ischemic attacks for more than two days has been associated with 2-5 times higher hospitalization costs (
25). Fine et al. (2000) reported a considerable reduction in expenses after 1-day reduction in hospitalization period for patients with community-acquired pneumonia (
26).
In this study, the selection of antibiotics was based on the antimicrobial sensitivity test in 84 % of patients who received antibiotics on an empirical basis and only in 16% of children. It is noteworthy that most of the hospitalized children were referred from other pediatric departments in Kerman Province and were received antibiotics before admission. Similar studies in different countries, including Singapore (
27), Tennessee state in the United States (
28), Tanzania (
29), Nepal (
15) , India (
14), and Ethiopia (
13) reported the empirical antibiotic therapy for hospitalized children. Wang et al. (2019) reported inappropriate empirical antibiotic choice in children hospitalized for atopic dermatitis (
30)
Antimicrobial sensitivity test showed that ampicillin was associated with the highest rate of resistance to prescribed antibiotics (83.9%), followed by clindamycin (81.0%). Also, the resistance rate to other prescribed antibiotics was relatively high, ranging from 8.0% to meropenem, 26.7% to cefotaxime, 32.0% to vancomycin, and 33.0% to ceftriaxone, which is higher than the resistance rate to ampicillin (74.2%), ceftriaxone (7.5%), and co-trimoxazole (61.3%) in Turkish children with urinary tract infections, and 5% resistance to cefotaxime in the United States (
31). Similar studies on high resistance rate of commonly used antibiotics in Iranian hospitalized children have been reported previously (
32-
34). Ghorashi et al. (2011) reported that more than 95% of isolated pathogens from children’s urinary tract infections were resistant to ampicillin and resistance rate to cefotaxime and ceftriaxone was 27.6% and 22.4%, respectively (
32). In agreement with our results, Mehrgan et al. (2008)) reported that extended-spectrum β-lactamase-producing (ESBL)
Escherichia coli (
E. coli) were highly susceptible to imipenem (100%), amikacin (91.1%), and piperacillin/tazobactam (85.2%) (
33). Contrary to our results, Rezai et al. (2015) reported a very high resistance rate of ESBL-producing
E. coli isolates to cefixime (99%), colistin (82%), and ciprofloxacin (76%) among pediatrics in the North of Iran (
34). Also, Kocak et al. (2016) reported a high rate of antimicrobial resistance among ESBL-producing
E. coli to the 3rd generation cephalosporins in Turkish children hospitalized for urinary tract infection (
35). Previous studies demonstrate that hospitalization is the major risk factor for the emergence and expansion of methicillin-resistant
staphylococcus aureus (MRSA) in the community (
36).
However, inadequate antibiotic use for the treatment of bacterial infections is an important factor in the emergence and expansion of antibiotic-resistant bacterial species. Group discussion of treatment guidelines and workshops for rational antibiotic prescription can improve the use of antimicrobials in hospitalized children.
Inappropriate use of antibiotics is a common problem in medicine. Also, the prescription of unapproved or off-label antibiotics in hospitalized children is common and off-label for dose is the most prevalent category (
37). So, accurate prescription of antibiotics must be observatory for not only for high-cost antibiotics but also for all antibiotics. The increased use of newer antibiotics is associated with an overall rise in healthcare costs as well as the faster development of bacterial resistance and the emergence of antibiotic-resistant microbial species throughout the world (
9). So healthcare professionals should apply strategies for monitoring and control of antibiotic use to reduce both antibiotic resistance and adverse events. Strategies for reduction of prescription of wide-spectrum antibiotics, including 2nd and 3rd generation cephalosporins, carbapenems, and quinolones, can be useful for the prevention of antimicrobial resistance (
38).
5.1. Conclusions
Our results indicate inappropriate use of antibiotics in hospitalized children. Ceftriaxone, an expensive 3rd generation cephalosporin, was the most frequently prescribed antibiotic. Results showed a high rate of antimicrobial resistance to the most commonly prescribed antibiotics, and moderate resistance to the more expensive antibiotics was observed in hospitalized children. Although prescription of low-cost antibiotics should be encouraged; however, the prescription of high-cost antibiotics, including ceftriaxone, vancomycin, and meropenem, should be allowed merely on the basis of antimicrobial sensitivity tests. So rational and appropriate use of antibiotics by health professionals, through the selection of antibiotics using antimicrobial sensitivity test, as well as an appropriate dose and duration, is of vital importance.